Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_034209895.1 N787_RS00095 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000747155.1:WP_034209895.1 Length = 399 Score = 456 bits (1173), Expect = e-133 Identities = 244/390 (62%), Positives = 287/390 (73%), Gaps = 5/390 (1%) Query: 4 LGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLD 63 LGT L A RV+LLGSGELGKEVAIE QRLGVEVIA DRY DAPAM VAHRSH +NMLD Sbjct: 9 LGTPLSAGARRVLLLGSGELGKEVAIELQRLGVEVIAADRYDDAPAMQVAHRSHTLNMLD 68 Query: 64 GDALRRVVELEKPHYIVPEIEAIATDMLIQLE-EEGLNVVPCARATKLTMNREGIRRLAA 122 ALR ++ EKP +VPEIEAI T L++LE ++G +VVP ARA +LTM+REGIRRLAA Sbjct: 69 PAALRDLIAHEKPDLVVPEIEAIHTPTLVELEADKGQHVVPTARAARLTMDREGIRRLAA 128 Query: 123 EELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQ 182 E L LPTS YRF D+ + AVA IG PC+VKPVMSSSGKGQ+ +RS + AW+YAQ Sbjct: 129 ETLGLPTSPYRFVDTREDYLAAVAAIGLPCVVKPVMSSSGKGQSTVRSEADIDAAWEYAQ 188 Query: 183 QGGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSPL 242 GGR G GR IVEG ++FD+EITLLTV DG FC P+GH Q DGDYRESW PQ MS Sbjct: 189 TGGRTGQGRCIVEGFIRFDYEITLLTVRHRDGTSFCDPIGHLQVDGDYRESWMPQPMSAR 248 Query: 243 ALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFAL 302 AL+R+QEIAR + LGG+GLFGVELFV GDEV FSEVSPRPHDTG+VTL+SQ+LSEFAL Sbjct: 249 ALQRSQEIARAITDDLGGHGLFGVELFVQGDEVWFSEVSPRPHDTGLVTLVSQELSEFAL 308 Query: 303 HVRAFLGLPVGGIRQYGPAASAVILPQLTSQNV-TFDNVQNAVG-ADLQIRLFGKPEIDG 360 H RA LGLP+ IR GP+AS +L T V F +V A+ D +RLFGKP ++G Sbjct: 309 HARAILGLPIPNIRTLGPSASCAVL--ATGHGVPEFSHVDAALAEPDTALRLFGKPRVEG 366 Query: 361 SRRLGVALATAESVVDAIERAKHAAGQVKV 390 RR+ V LA E + A +A+ AA + V Sbjct: 367 HRRVAVTLARDEDIESARAKARRAAAALGV 396 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 481 Number of extensions: 20 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 399 Length adjustment: 31 Effective length of query: 361 Effective length of database: 368 Effective search space: 132848 Effective search space used: 132848 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory